Monthly Archive: April 2018

Hemp users report recurrent reductions in anxiety, increased relaxation and tension relief. A survey of approximately 4400 people suggested that those who consumed hemp daily or weekly reported a decrease in depressed mood, and an increase in positive effect, compared to respondents who stated they never used hemp. However, the study suffered from a series of serious drawbacks and therefore must be interpreted with caution. The fact is that hemp oil for pain and anxiety works well!

Preclinical and clinical evidence indicates an important role of the endocannabinoid system in anxiety and depression. Results of studies in animals suggest that low doses of agonists (activators) of CB1 receptors reduce anxious behaviour and increase anti-depressant responses. Also, agonists of CB1 receptors appear to improve central serotonergic and noradrenergic neurotransmission, similarly to the action of antidepressant medications. But on the other hand, high-level stimulations of the CB1 receptor, or the administration of CB1 receptor antagonists, reverse this response and may trigger depression.

The suppression of endocannabinoid system signalling is sufficient to induce a depressive state in both animals and humans. In addition, concentrations of endocannabinoids have been found to be significantly reduced in women with major depression. These findings suggest that the proper tone of endocannabinoids plays an important role in mood regulation.

First, it is important to note that the routine use of hemp or cannabinoid-based medications to treat anxiety or primary depression should be considered with caution, especially discouraging its use to people with a history of psychotic disorders., limited clinical evidence indicates that these drugs may be alternative therapeutic pathways in patients suffering from anxiety or depression secondary to certain chronic diseases. For example, in a study of HIV + patients who reported using hemp to manage their symptoms, 93% cited an improvement in anxiety and 86% cited an improvement in depression.

However, it is important to bear in mind that 47% of respondents also reported deterioration in memory, which may be due to both the use of hemp and the effects of the disease. Mood improvement was also reported as a beneficial effect of hemp use in patients suffering from multiple sclerosis. Equally,

Hemp oil for pain and anxiety

Growing evidence suggests an important role of cannabidiol (CBD) in the decrease of anxiety, although the degree to which the CBD (at concentrations that are commonly found in hemp) is able to achieve this effect remains uncertain. Preclinical studies have shown that CBD and CBD derivatives decreased anxious behaviour in a rat model. A clinical study of the year 1980 showed that the CBD (1 mg/kg) attenuated the anxiogenic effects produced by THC (0.5 mg/kg) in eight healthy volunteers with a history of marijuana use. Another double-blind clinical trial demonstrated that a single dose of CBD (400 mg) significantly reduced anticipatory anxiety, but increased mental sedation, although results were considered preliminary and more follow-up studies were suggested. Imaging studies of the brain by computed tomography (SPECT) showed that, in contrast to placebo, the CBD decreased regional cerebral blood flow in the limbic and paralímbic cortical areas, regions involved in the pathophysiology of anxiety.

On the other hand, a more recent double-blind, randomized, placebo-controlled study showed that 600 mg of CBD administered orally was associated with a significant reduction in anxiety, cognitive decline, and discomfort in patients suffering from social anxiety disorder generalized subject to a simulated test of public speaking. The authors caution that the study is of a preliminary nature and that larger and well-controlled additional studies are necessary to support this effect. Although In contrast to placebo, the CBD decreased regional cerebral blood flow in the limbic and paralimbic cortical areas, regions involved in the pathophysiology of anxiety. On the other hand, a more recent double-blind, randomized, placebo-controlled study showed that 600 mg of CBD administered orally was associated with a significant reduction in anxiety, cognitive decline, and discomfort in patients suffering from social anxiety disorder generalized subject to a simulated test of public speaking.

The authors caution that the study is of a preliminary nature and that larger and well-controlled additional studies are necessary to support this effect. Although In contrast to placebo, the CBD decreased regional cerebral blood flow in the limbic and paralimbic cortical areas, regions involved in the pathophysiology of anxiety. On the other hand, a more recent double-blind, randomized, placebo-controlled study showed that 600 mg of CBD administered orally was associated with a significant reduction in anxiety, cognitive decline, and discomfort in patients suffering from social anxiety disorder generalized subject to a simulated test of public speaking.

The authors caution that the study is of a preliminary nature and that larger and well-controlled additional studies are necessary to support this effect. On the other hand, a more recent double-blind, randomized, placebo-controlled study showed that 600 mg of CBD administered orally was associated with a significant reduction in anxiety, cognitive decline, and discomfort in patients suffering from social anxiety disorder generalized subject to a simulated test of public speaking. The authors caution that the study is of a preliminary nature and that larger and well-controlled additional studies are necessary to support this effect.

On the other hand, a more recent double-blind, randomized, placebo-controlled study showed that 600 mg of CBD administered orally was associated with a significant reduction in anxiety, cognitive decline, and discomfort in patients suffering from social anxiety disorder generalized subject to a simulated test of public speaking. The authors caution that the study is of a preliminary nature and that larger and well-controlled additional studies are necessary to support this effect. Although cognitive impairment, and discomfort in patients suffering from generalized social anxiety disorder subjected to a sham test of public speaking. The authors caution that the study is of a preliminary nature and that larger and well-controlled additional studies are necessary to support this effect.

Although cognitive impairment, and discomfort in patients suffering from generalized social anxiety disorder subjected to a sham test of public speaking. The authors caution that the study is of a preliminary nature and that larger and well-controlled additional studies are necessary to support this effect. although the precise mechanism by which CBD exerts its anxiolytic effects is not well established, it can act either by decreasing the blood flow to regions of the brain associated with the processing of anxiety or by fear-based stimuli or possibly by through the modulation of serotonergic neurotransmission.